Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies

References

• LegendreDPMuznyCASwiatloEHansen’s disease (leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactionsPharmacotherapy201232273722392826
   PubMed Web of Science ®Google Scholar
• DhopleAMIn vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium lepraeInt J Antimicrob Agents19991231932310493608
   PubMed Web of Science ®Google Scholar
• ZhuYIStillerMJDapsone and sulfones in dermatology: overview and updateJ Am Acad Dermatol20014542043411511841
   PubMed Web of Science ®Google Scholar
• WozelVEInnovative use of dapsoneDermatol Clin20102859961020510768
   PubMed Web of Science ®Google Scholar
• LindenbergMKoppSDressmanJBClassification of orally administered drugs on the World Health Organization model list of essential medicines according to the Biopharmaceutics classification systemEur J Pharm Biopharm20045826527815296954
   PubMed Web of Science ®Google Scholar
• YuanYLiSMoFZhongDInvestigation of microemulsion system for transdermal delivery of meloxicamInt J Pharm200632111712316876972
   PubMed Web of Science ®Google Scholar
• JainJFernandesCPatravaleVFormulation development of parenteral phospholipid-based microemulsion of etoposideAAPS Pharm Sci Tech201011826831
   PubMed Web of Science ®Google Scholar
• NandiIBariMJoshiHStudy of isopropyl myristate microemulsion systems containing cyclodextrins to improve the solubility of two model hydrophobic drugsAAPS Pharma Sci Tech20034E10
   PubMedGoogle Scholar
• NornooAOZhengHLopesLBRestrepoBJKannanKReedROral microemulsions of paclitaxel: in situ and pharmacokinetic studiesEur J Pharm Biopharm20097131031718793723
   PubMed Web of Science ®Google Scholar
• MoulikSPPaulBKStructure, dynamics and transport properties of microemulsionsAdv Colloid Interface Sci19987899195
   Web of Science ®Google Scholar
• LawrenceMJReesGDMicroemulsion-based media as novel drug delivery systemsAdv Drug Deliv Rev2000458912111104900
   PubMed Web of Science ®Google Scholar
• International Conference on HarmonizationQ1A(R2). Stability testing of new drug substance and productsUS Food and Drug Administration Federal Register2003 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdfAccessed October 4, 2011
   Google Scholar
• QueirozRHCDreossiSACarvalhoDJPotentiation the effect methe-moglobinemia dapsone in rats by N-acetylcysteineJ Anal Toxicol1997212032079171203
   PubMed Web of Science ®Google Scholar
• US Pharmacopeia NF-28 1092The Dissolution Procedure: Development and Validation33th edRockville, MDUS Pharmacopeia2010
   Google Scholar
• CostaPLoboJMSModeling and comparison of dissolution profilesEur J Pharm Sci20011212313311297896
   PubMed Web of Science ®Google Scholar
• BiganzoliECavenaghiALRossiRBrunatiCMNolliLMUse of a Caco-2 cell culture model for the characterization of intestinal absorption of antibioticsIl Farmaco19995459459910555261
   PubMedGoogle Scholar
• CalatayudMGimenoJVélezDDevesaVMontoroRCharacterization of the intestinal absorption of arsenate, monomethylarsonic acid, and dimethylarsinic acid using the Caco-2 cell lineChem Res Toxicol20102354755620078116
   PubMed Web of Science ®Google Scholar
• SandriGBonferoniMCRossiSFerrariFBoselliCCaramellaCInsulin-loaded nanoparticles based on n-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement propertiesAAPS Pharma Sci Tech201011362371
   PubMed Web of Science ®Google Scholar
• MarkowskaMOberleRJuzwinSHsuCPGryszkiewiczMStreeterAJOptimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysisJ Pharmacol Toxicol Methods200146515512164260
   PubMed Web of Science ®Google Scholar
• RanaldiGIslamKSambuyYEpithelial cells in culture as a model for the intestinal transport of antimicrobial agentsAntimicrob Agents Chemother199236137413811510430
   PubMed Web of Science ®Google Scholar
• GrbicSParojcicJIbricSDjuricZIn vitro-in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulationAAPS Pharm Sci Tech201112165171
   PubMed Web of Science ®Google Scholar
• OkumuADimasoMLobenbergRComputer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug productsEur J Pharm Biopharm200972919819056493
   PubMed Web of Science ®Google Scholar
• WeiHLöbenbergRBiorelevant dissolution media as a predictive tool for glyburide a class II drugEur J Pharm Sci200629455216815694
   PubMed Web of Science ®Google Scholar
• TangJLSunJHeZGSelf-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugsCurr Drug Ther200728593
   Google Scholar
• LuoMShenQChenJTransdermal delivery of paeonol using cubic gel and microemulsion gelInt J Nanomedicine201161603161021904450
   PubMed Web of Science ®Google Scholar
• YangSGursoyRNLambertGBenitaSEnhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitorsPharm Res20042126127015032307
   PubMed Web of Science ®Google Scholar
• SharmaGWilsonKVan der WalleCFSattarNPetrieJRRavi KumarMNVMicroemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic ratsEur J Pharm Biopharm20107615916920655382
   PubMed Web of Science ®Google Scholar
• DateAANagarsenkerMSParenteral microemulsions: an overviewInt J Pharm2008355193018295991
   PubMed Web of Science ®Google Scholar
• GursoyNGarrigueJSRazafindratsitaALambertGBenitaSExcipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery systemJ Pharm Sci2003922411241814603486
   PubMed Web of Science ®Google Scholar
• NornooAOOsborneDWChowDSLCremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysisInt J Pharm200734910811617869459
   PubMed Web of Science ®Google Scholar
• LamKWXuJNgKMPharmaceutical salt formation guided by phase diagramsInd Chem Res2010491250312512
   Web of Science ®Google Scholar
• YeeSIn vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man – fact or mythPharm Res1997147637669210194
   PubMed Web of Science ®Google Scholar
• TalegaonkarSAzeemAAhmadFJKharRKPathanSAKhanZIMicroemulsion: a novel approach to enhanced drug deliveryRecent Pat Drug Deliv Formul2008223825719075911
   PubMedGoogle Scholar
• KoganAGartiNMicroemulsions as transdermal delivery vehiclesAdv Colloid Interface Sci2006123–126369385
   PubMed Web of Science ®Google Scholar
• PorterCJHTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov2007623124817330072
   PubMed Web of Science ®Google Scholar
• MirochnickMClarkeDFMcNamaraERCabralHBioequivalence of a propylene glycol-based liquid dapsone preparation and dapsone tabletsAm J Health Syst Pharm2000571775177711030029
   PubMed Web of Science ®Google Scholar